PLUMBAGO ROSEA ROOT EXTRACT.

The concept of 'dusting' an ingredient for marketing at an ineffective concentration is less relevant here. The primary concern with Plumbago Rosea Root Extract is its inherent irritancy and toxicity, even at potentially low concentrations. Its main active component, plumbagin, is described as a 'powerful irritant' and has shown in vitro cytotoxic effects at ≥500µg/mL, suggesting that any inclusion in a cosmetic formulation carries significant risk, regardless of efficacy concerns.

No official CIR, SCCS, or FDA safety status has been established. Toxicity studies reveal significant concerns: acute oral LD50 in mice was 1148.15 mg/kg body weight, with doses above 1250 mg/kg causing severe diarrhea. Subacute daily doses of 50 mg/kg in rats for 30 days led to no weight gain, altered organ weights, and elevated white blood cell counts. Plumbagin, the principal active compound, is explicitly noted as a 'powerful irritant in small doses' and can have adverse effects on the central nervous system. An in vitro study observed cell death and cytotoxic effects in human lymphocytes at concentrations ≥500µg/mL. A prominent industry review indicates that despite potential benefits, this ingredient is 'proven to do more harm than good,' carrying a 'likelihood of irritation' that increases when combined with other problematic ingredients, potentially leading to irritation, inflammation, and dryness.